HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 99Generated: October 23, 2026
Piperazine, 2-pyridylethyl- → Ethyl 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate
https://huagongshe.com/en/reaction/99
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine, 2-pyridylethyl- | HCID 566605 | — |
| Reactant | Ethyl 7-bromobenzofuran-2-carboxylate | HCID 46738833 | — |
| Reagent | Cesium carbonate | HCID 10796 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Catalyst | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | Ethyl 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate | HCID 59636751 | 18.97% |
Reaction Steps
The reaction mixture of ethyl 7-bromobenzofuran-2-carboxylate (2.0 g, 7.43 mmol), 1-(2-(pyridin-2-yl)ethyl)piperazine (1.564 g, 8.18 mmol), Tris(dibenzylideneacetone)dipalladium(0) (0.476 g, 0.52 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (0.496 g, 1.04 mmol) and Cesium carbonate (3.63 g, 11.15 mmol) in dioxane (30 mL) (degassed with argon for 10 min) was heated at 95 °C under argon for 5 h. After cooling, the reaction mixture was filtered and concentrated. The product was purified twice by isco, the first using DCM:MeOH (0-5%) and the second time using DCM:MeOH (0-3%).
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-d491779c6ebc428d97eb810ae5444bf6 |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|